Membranolytic peptide programs immunogenic cell death for cancer therapy

Nature 2026

View at publisher
Authors: Yueling Yuan, Lifang Liang, Jie Li, Chengrun Li, Fuxiang Wang, Kai Yan, Chanjuan Su, Jingxian Chen, Fan Lan, Zining Wu, Rupei Du, Yaofeng Zhou
+17 more Xiongwei Xiang, Jueqiong Xu, 周火生, Long Zou, Zhouming Zhang, Yuhao Zhang, Songyin Huang, Yajing Zhang, Penghui Zhou, Tianmeng Sun, Kaiting Yang, Zhi-Bin Zhao, Zhe‐Xiong Lian, Shiyan Xiao, Jianjun Cheng, Yan Bao, Menghua Xiong
DOI: 10.1038/s41586-026-10899-5
Cited by: 1
References: 59

Fields of Study & Subjects

Immunotherapy and Immune Responses CAR-T cell therapy research RNA Interference and Gene Delivery

Publication details

Journal / source
Nature
Publisher
Springer Science and Business Media LLC
Volume
658
Issue
8134
Pages
230-240
Publication date
5 August 2026
Language
EN